Invention Grant
US12054458B2
有权
- Patent Title:
-
Application No.: US18186043Application Date: 2023-03-17
-
Publication No.: US12054458B2Publication Date: 2024-08-06
- Inventor: Jens Cardinale , Martin Schaefer , Klaus Kopka , Matthias Eder , Ulrike Bauder-Wuest , Michael Eisenhut , Martina Benesova , Uwe Haberkorn , Frederik L. Giesel
- Applicant: DEUTSCHES KREBSFORSCHUNGSZENTRUM , RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Applicant Address: DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM,RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
- Current Assignee Address: DE Heidelberg; DE Heidelberg
- Agency: Perkins Coie LLP
- Agent Viola Kung
- Priority: EP 002800 2015.09.30 EP 164090 2016.04.06 EP 182764 2016.08.04
- Main IPC: C07D213/61
- IPC: C07D213/61 ; A61K38/00 ; A61K51/04 ; A61P35/00 ; C07B59/00 ; C07K7/02 ; G01N33/574
Abstract:
The present invention generally relates to the field of radiopharmaceuticals and their use in nuclear medicine as tracers and imaging agents for various disease states of prostate cancer.
Public/Granted literature
Information query
